Literature DB >> 7334363

Effect of melatonin on experimental tumors under different photoperiods and times of administration.

H Bartsch, C Bartsch.   

Abstract

The effects of melatonin on experimental tumors so far described in the literature are contradictory. This may partially be due to negligence of the importance of environmental photoperiodic conditions and to the time of day of administration. In order to test whether the effect of melatonin on day of administration. In order to test whether the effect of melatonin on tumor growth is dependent on the photoperiod and the time of day of administration, the present experiments were carried out. It appears that under long photoperiods melatonin shows opposite effects on fibrosarcoma ascites and Ehrlich solid tumors depending on the time of the day at which the compound was administered. Tumor are stimulated by melatonin injections in the morning and inhibited by late afternoon injections. Experiments under L:D=12:12 and L:D=8:16 do not show such pronounced antagonistic effects. These results support our hypothesis that the effect of melatonin on tumor growth is dependent on the photoperiod and the time of day of administration. Possible mechanisms involved in these effects are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7334363     DOI: 10.1007/bf01256752

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  21 in total

1.  [Influence of the epiphysis on the growth of transplantable tumor implants].

Authors:  H KALLENBACH; W MALZ
Journal:  Endokrinologie       Date:  1957-08

2.  Reversal by melatonin of the effect of pinealectomy on tumor growth.

Authors:  A A el-Domeiri; T K Das Gupta
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  [A decrease in the excretion of antigonadotropic factor in patients with cancer of the uterine body and breast].

Authors:  M N Ostroumova
Journal:  Vopr Onkol       Date:  1972

4.  [Decrease in the excretion of antigonadotropic factor in patients with cancer of the uterine cervix and prostate gland. Experimental antitumor effect of an epiphyseal extract].

Authors:  M N Ostroumova; V N Anisimov; A A Syromiatnikov; V M Dil'man
Journal:  Vopr Onkol       Date:  1976

5.  Letter: The pineal and neoplasia.

Authors:  R S Buswell
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

6.  Further studies on gonadotropin-inhibiting substances excreted in human urine.

Authors:  M Ota; N Sato; K Obara
Journal:  Endocrinol Jpn       Date:  1977-12

7.  Effects of some low molecular weight sheep pineal fractions and melatonin on different tumors in rats and mice.

Authors:  V Lapin; I Ebels
Journal:  Oncology       Date:  1976       Impact factor: 2.935

8.  Subcutaneous melatonin implants inhibit reproductive atrophy in male hamsters induced by daily melatonin injections.

Authors:  R J Reiter; P K Rudeen; J W Sackman; M K Vaughan; L Y Johnson; J C Little
Journal:  Endocr Res Commun       Date:  1977

9.  A survey of the location, isolation and identification of indoles, pteridines and some unknown active substances in sheep pineals. The possible significance of pteridines for the neuroendocrine control of neoplastic growth.

Authors:  I Ebels
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

10.  Urinary melatonin levels in human breast cancer patients.

Authors:  C Bartsch; H Bartsch; A K Jain; K R Laumas; L Wetterberg
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

View more
  16 in total

Review 1.  The therapeutic potential of melatonin: a review of the science.

Authors:  Samir Malhotra; Girish Sawhney; Promila Pandhi
Journal:  MedGenMed       Date:  2004-04-13

Review 2.  Schedule shifts, cancer and longevity: good, bad or indifferent?

Authors:  Germaine Cornélissen; Julia Halberg; Franz Halberg; Salvador Sanchez de la Pena; Walter Nelson; Othild Schwartzkopff; Alexander Stoynev; Erhard Haus
Journal:  J Exp Ther Oncol       Date:  2008

3.  Growth-inhibiting effect of crude pineal extracts on human melanoma cells in vitro is different from that of known synthetic pineal substances.

Authors:  H Bartsch; C Bartsch; H P Noteborn; B Flehmig; I Ebels; C A Salemink
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

4.  Partial purification of (a) low molecular weight ovine pineal compound(s) with an inhibiting effect on the growth of human melanoma cells in vitro.

Authors:  H P Noteborn; H Bartsch; C Bartsch; D R Mans; J J Weusten; B Flehmig; I Ebels; C A Salemink
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

5.  Urinary melatonin levels in human breast cancer patients.

Authors:  C Bartsch; H Bartsch; A K Jain; K R Laumas; L Wetterberg
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

6.  Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119).

Authors:  Lawrence Berk; Brian Berkey; Tyvin Rich; William Hrushesky; David Blask; Michael Gallagher; Mahesh Kudrimoti; Ronald C McGarry; John Suh; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-06       Impact factor: 7.038

7.  Studies on the effects of the pineal hormone melatonin on an androgen-insensitive rat prostatic adenocarcinoma, the Dunning R 3327 HIF tumor.

Authors:  G R Buzzell
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

8.  Melatonin: a novel indolamine in oral health and disease.

Authors:  V K Chava; K Sirisha
Journal:  Int J Dent       Date:  2012-07-31

9.  Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.

Authors:  P Lissoni; E Tisi; S Barni; A Ardizzoia; F Rovelli; R Rescaldani; D Ballabio; C Benenti; M Angeli; G Tancini
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

10.  Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.

Authors:  P Lissoni; S Barni; G Tancini; A Ardizzoia; F Rovelli; M Cazzaniga; F Brivio; A Piperno; R Aldeghi; D Fossati
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.